Why is Welcure Drugs falling/rising?

As of 22-Sep, Welcure Drugs & Pharmaceuticals Ltd is currently priced at 7.42, reflecting a rise of 0.04 or 0.54%. Despite this slight increase today, the stock has shown significant declines over the past week and month, with returns of -11.56% and -37.75%, respectively. The stock is trading below all its moving averages, indicating a bearish trend. Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 62.27% compared to the 5-day average, suggesting reduced interest from investors. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, while the Sensex has gained 0.46% over the past week and 1.05% over the past month, Welcure Drugs has significantly underperformed, highlighting a stark contrast in performance. The stock's year-to-date decline of -36.42% also contrasts with the Sensex's positive return of 5.15%, indicating that the broader market is performing better than Welcure Drugs. This disparity in performance may contribute to the stock's current price movement, as investors may be favoring more stable options in the market.